Mark Luscher Email

VP, Scientific Affairs . Microbix

Current Roles

Employees:
115
Revenue:
$17.8M
About
Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: \r\n\r\nVIRUSMAX Influenza Virus Yield Enhancement Technology\r\nLumiSort™ Gender Selection Technology \r\nKinlytic® (Urokinase) Thrombolytic Drug
Microbix Address
265 Watline Ave.
Mississauga, ON
CAN

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.